Clinical Trials Browser

Phase NA × PEGPH20 × Gastrointestinal × Clear all

NCT02921022 2025-11-26

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Phase NA Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

NCT02241187 2017-09-27

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Phase NA Completed

2 enrolled 4 charts

Gastrointestinal

Pancreatic Neoplasms